Variable | Categories of variable | Total Patients (N = 676) (Column %) | SIMD 1 (least deprived) (N = 181) | SIMD 2 (N = 172) | SIMD 3 (N = 145) | SIMD 4 (N = 114) | SIMD 5 (most deprived) (N = 64) |
---|---|---|---|---|---|---|---|
Event type | Dead, no recurrence | 105 (15.5%) | 24 (13.3%) | 28 (16.3%) | 21 (14.5%) | 23 (20.2%) | 9 (14.1%) |
Alive, no recurrence | 386 (57.1%) | 118 (65.2%) | 98 (57.0%) | 73 (50.3%) | 64 (56.1%) | 33 (51.6%) | |
Recurrence (+/− death following recurrence) | 185 (27.4%) | 39 (21.5%) | 46 (26.7%) | 51 (35.2%) | 27 (23.7%) | 22 (34.4%) | |
Cause of deatha | Breast cancer | 116 (46.8%) | 24 (44.4%) | 27 (43.5%) | 34 (55.7%) | 18 (40.9%) | 14 (48.1%) |
Non breast cancer death | 61 (24.6%) | 14 (25.9%) | 15 (24.2%) | 10 (16.4%) | 16 (36.4%) | 6 (22.2%) | |
Tumour grade | Grade 1/2 | 105 (16.1%) | 32 (18.6%) | 22 (13.4%) | 20 (14.3%) | 23 (20.4%) | 8 (12.5%) |
Grade 3 | 548 (83.9%) | 140 (81.4%) | 142 (86.6%) | 120 (85.7%) | 90 (79.6%) | 56 (87.5%) | |
TNM stage | I | 131 (32.7%) | 34 (34.7%) | 33 (33.0%) | 21 (23.6%) | 23 (32.4%) | 20 (46.5%) |
II/III | 270 (67.3%) | 64 (65.3%) | 67 (67.0%) | 68 (76.4%) | 48 (67.6%) | 23 (53.5%) | |
Age at diagnosis | < 50 | 186 (27.5%) | 46 (25.4%) | 46 (26.7%) | 44 (30.3%) | 32 (28.1%) | 18 (28.1%) |
50–70 | 348 (51.5%) | 100 (55.2%) | 91 (52.9%) | 71 (49.0%) | 54 (47.4%) | 32 (50.0%) | |
70 + | 142 (21.0%) | 35 (19.3%) | 35 (20.3%) | 30 (20.7%) | 28 (24.6%) | 14 (21.9%) | |
Treatment received | Breast-conserving surgery | 335 (49.6%) | 91 (50.3%) | 83 (48.3%) | 69 (47.6%) | 54 (47.4%) | 38 (59.4%) |
Mastectomy | 341 (50.4%) | 90 (49.7%) | 89 (51.7%) | 76 (52.4%) | 60 (52.6%) | 26 (40.6%) | |
Chemotherapy | 513 (76.0%) | 137 (75.7%) | 132 (77.2%) | 108 (74.5%) | 86 (75.4%) | 50 (78.1%) | |
Radiotherapy | 492 (73.2%) | 134 (74.4%) | 126 (73.7%) | 103 (71.0%) | 82 (73.2%) | 47 (73.4%) | |
Screeningb | Screen detected | 114 (32.8%) | 28 (28.0%) | 26 (28.6%) | 26 (36.6%) | 19 (35.2%) | 15 (46.9%) |
Not screen detected | 234 (67.2%) | 72 (72.0%) | 65 (71.4%) | 45 (63.4%) | 35 (64.8%) | 17 (53.1%) |